Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin-treated breast cancer patients: a prospective exploratory study

Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin-treated breast cancer patients: a prospective exploratory study

Abstract Background Soluble urokinase plasminogen activator receptor is an inflammatory biomarker that may prognosticate cardiovascular outcomes. We sought to determine the associations between soluble urokinase plasminogen activator receptor and established markers of cardiotoxicity in breast cance...

Full description

Bibliographic Details
Main Authors: Jian Chu, Lillian Tung, Issam Atallah, Changli Wei, Melody Cobleigh, Ruta Rao, Steven B. Feinstein, Lydia Usha, Kathrin Banach, Jochen Reiser, Tochukwu M. Okwuosa
Format: Article
Language:English
Published: BMC 2024-01-01
Series:Cardio-Oncology
Subjects:
Soluble urokinase Plasminogen Activator Receptor (suPAR)
Biomarker
Global longitudinal strain (GLS)
Echocardiography
B-type natriuretic peptide (BNP)
Troponin
Online Access:https://doi.org/10.1186/s40959-023-00191-0

Internet

https://doi.org/10.1186/s40959-023-00191-0

Similar Items